Key facts
- Quanta Dialysis Technologies’s last known valuation is $555.1M.
- It has raised $425.3M; the latest was Later Stage VC ($60.3M) in Nov 2024.
- Notable investors include Puhua Capital, Novo Holdings, BlackRock, b2venture, Sands Capital — 29 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 29 names
- ·Watchlist + deal alerts for Quanta Dialysis Technologies
- ·The full record, as it builds
Funding rounds
No funding rounds for Quanta Dialysis Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Quanta Dialysis Technologies
Manufacturer of a medical device intended to improve dialysis experiences and kidney care. The company's dialysis machine is high-performing, small and simple, supports high dialysate flow rates, and provides real-time feedback, enabling healthcare providers to treat more patients efficiently and to take control of their lives with self-care and home dialysis.
- Sector
- Healthcare
- HQ
- Warwick, United Kingdom
- Founded
- 2008
- Employees
- 238
- Website
- quantadt.com/
- Ownership
- Privately Held (backing)
Quanta Dialysis Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Quanta Dialysis Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Quanta Dialysis Technologies in its N-PORT filings yet. We sweep new filings monthly.